PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.50%
Negative net income growth while ORCL stands at 44.33%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
46.59%
D&A growth well above ORCL's 4.28%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-411.45%
Negative yoy deferred tax while ORCL stands at 283.33%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.17%
Both cut yoy SBC, with ORCL at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-4097.62%
Both reduce yoy usage, with ORCL at -285.83%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-217.75%
Both yoy AR lines negative, with ORCL at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.48%
Some yoy usage while ORCL is negative at -395.44%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
463.41%
Well above ORCL's 111.86%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-49.72%
Both yoy CFO lines are negative, with ORCL at -85.03%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-39.17%
Both yoy lines negative, with ORCL at -16.33%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
62.80%
Some acquisitions while ORCL is negative at -16.89%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
29.19%
Purchases well above ORCL's 25.06%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-55.09%
We reduce yoy sales while ORCL is 143.30%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-276.52%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-130.30%
We reduce yoy invests while ORCL stands at 71.92%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
1055.58%
Stock issuance far above ORCL's 149.38%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
24.55%
We have some buyback growth while ORCL is negative at -6.84%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.